Board of Directors

• Dr. James A. Manganello, Chairman of the Board
• James S. Sigler, Board Member
• Howard Greenman, Chief Executive Officer

Dr. James A. Manganello, Chairman of the Board

Dr. Manganello joined Provia as the Chairman of the Board and consultant.  Clinically trained in the Department of Psychiatry at Harvard Medical School & the Massachusetts General Hospital, he earned his post-doctorate Masters in Public Health from the Harvard School of Public Health. Over the last 35 years, Dr. Manganello has been an entrepreneur in multiple settings involving outpatient health care delivery, medical device company start-ups and international consulting to health care delivery systems. He most recently co-founded, developed and sold a medical device company yielding significant returns for investors.  He is on the Board of privately held companies as well as not-for-profit organizations.

Dr. Manganello actively consults Officials at the United Nations and World Health Organization on matters of Psychiatry and Public Health. Back to Top ⇧

James S. Sigler, Board member

Mr. Sigler was formerly a director of ViaCord (now part of PerkinElmer). Mr. Sigler has over 24 years of management experience, including 18 years in the development, manufacturing, and quality management of biological, cell therapy, and small molecule products. As an example, he was divisional head of manufacturing when Genzyme Corporation sought and received regulatory approval for Carticel, an autologous cell therapy product.

Mr. Sigler earned an MBA degree from Harvard Business School and a B.S. degree from Cornell University. Back to Top ⇧

Howard Greenman, Chief Executive Officer

Mr. Greenman was most recently Vice President and Interim CEO for HealthCare IT, Inc. (HCIT) – a biomedical software and services firm specializing in human tissue banking. While at HCIT, he formed partnerships with global pharmaceutical companies as well as major academic medical institutions to standardize the management of donated human specimens by using advanced logistics and clinical data management software and protocols. Prior to HCIT, Mr. Greenman led the strategic marketing function for Philips Medical System's Remote Patient Management Division, part of Philip's New Ventures organization. In this role, Mr. Greenman was responsible for commercialization and partnership strategy for a cardiovascular disease management platform technology. Prior to Philips, Mr. Greenman was Director of Business Development for Ardais Corporation, a biorepository management company that set the standard in tissue banking bioethics, logistics, and quality by building one of the largest repositories of research quality commercially available cancer tissue in the world. Mr. Greenman was the founder of medXtend Corporation, a venture backed healthcare services company providing medical devices and services for use by Radiologists and Primary Care Physicians. Additionally, Mr. Greenman worked in a variety of healthcare consulting roles within Accenture's Healthcare Practice, KPMG Peat Marwick's Healthcare Strategy Group, Oracle, and the Boston Consulting Group.

Mr. Greenman holds an M.B.A. from the Wharton School of Business in Healthcare Management. Back to Top ⇧